Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
36.88
-0.39 (-1.05%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Apogee Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover Apogee Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $95.4, which forecasts a 158.68% increase in the stock price over the next year. The lowest target is $87 and the highest is $116.

Price Target: $95.4 (+158.68%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$87$95.4$90$116
Change+135.90%+158.68%+144.03%+214.53%

Analyst Ratings

The average analyst rating for Apogee Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy333344
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total444455

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B of A Securities
B of A Securities
Strong Buy
Maintains
$78$87
Strong BuyMaintains$78$87+135.90%Aug 28, 2025
Guggenheim
Guggenheim
Strong Buy
Reiterates
$116
Strong BuyReiterates$116+214.53%Jul 2, 2025
Citigroup
Citigroup
Strong Buy
Initiates
$95
Strong BuyInitiates$95+157.59%Mar 13, 2025
Guggenheim
Guggenheim
Strong Buy
Reiterates
n/a
Strong BuyReiteratesn/an/aFeb 10, 2025
Guggenheim
Guggenheim
Strong Buy
Reiterates
n/a
Strong BuyReiteratesn/an/aDec 12, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.76
from -3.30
EPS Next Year
-5.88
from -4.76
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
------32.23M
Revenue Growth
-------
EPS
-17.63-3.36-3.30-4.76-5.88-6.58-5.63
EPS Growth
-------
Forward PE
-------
No. Analysts
---121293
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-4.54-4.31
Avg-4.76-5.88
Low-5.32-9.90

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.